John G Ullman & Associates Inc Thermo Fisher Scientific Inc. Transaction History

John G Ullman & Associates Inc

  • $630 Million
  • Q2 2024

A detailed history of John G Ullman & Associates Inc transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, John G Ullman & Associates Inc holds 13,470 shares of TMO stock, worth $8.27 Million. This represents 1.18% of its overall portfolio holdings.

Number of Shares
13,470
Previous 13,555 0.63%
Holding current value
$8.27 Million
Previous $7.88 Million 5.46%
% of portfolio
1.18%
Previous 1.25%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024
SELL
$541.52 - $599.02 $46,029 - $50,916
-85 Reduced 0.63%
13,470 $7.45 Million
Q1 2024

May 06, 2024
SELL
$528.82 - $599.43 $237,969 - $269,743
-450 Reduced 3.21%
13,555 $7.88 Million
Q4 2023

Jan 31, 2024
SELL
$431.41 - $532.94 $268,768 - $332,021
-623 Reduced 4.26%
14,005 $7.43 Million
Q3 2023

Nov 01, 2023
SELL
$498.29 - $574.41 $124,572 - $143,602
-250 Reduced 1.68%
14,628 $7.4 Million
Q2 2023

Aug 21, 2023
SELL
$508.46 - $591.13 $135,250 - $157,240
-266 Reduced 1.76%
14,878 $7.76 Million
Q1 2023

May 05, 2023
SELL
$535.0 - $604.82 $93,625 - $105,843
-175 Reduced 1.14%
15,144 $8.73 Million
Q4 2022

Feb 08, 2023
SELL
$484.71 - $571.37 $109,059 - $128,558
-225 Reduced 1.45%
15,319 $8.44 Million
Q3 2022

Oct 19, 2022
SELL
$507.19 - $604.49 $1.01 Million - $1.21 Million
-2,000 Reduced 11.4%
15,544 $7.88 Million
Q1 2022

Apr 29, 2022
SELL
$524.0 - $644.92 $63,928 - $78,680
-122 Reduced 0.69%
17,544 $10.4 Million
Q4 2021

Jan 26, 2022
SELL
$569.0 - $667.24 $71,125 - $83,405
-125 Reduced 0.7%
17,666 $11.8 Million
Q3 2021

Nov 02, 2021
SELL
$509.53 - $609.78 $101,906 - $121,956
-200 Reduced 1.11%
17,791 $10.2 Million
Q2 2021

Jul 23, 2021
SELL
$441.0 - $508.24 $61,740 - $71,153
-140 Reduced 0.77%
17,991 $9.08 Million
Q1 2021

Apr 22, 2021
SELL
$439.85 - $518.83 $233,560 - $275,498
-531 Reduced 2.85%
18,131 $8.28 Million
Q4 2020

Feb 05, 2021
SELL
$435.06 - $527.66 $38,720 - $46,961
-89 Reduced 0.47%
18,662 $8.69 Million
Q3 2020

Nov 06, 2020
SELL
$359.77 - $441.52 $1.55 Million - $1.9 Million
-4,303 Reduced 18.66%
18,751 $8.28 Million
Q2 2020

Jul 29, 2020
SELL
$275.2 - $362.34 $41,280 - $54,350
-150 Reduced 0.65%
23,054 $8.35 Million
Q1 2020

Apr 14, 2020
SELL
$255.3 - $340.05 $123,565 - $164,584
-484 Reduced 2.04%
23,204 $6.58 Million
Q4 2019

Jan 29, 2020
SELL
$271.93 - $328.04 $317,886 - $383,478
-1,169 Reduced 4.7%
23,688 $7.7 Million
Q3 2019

Oct 21, 2019
SELL
$268.46 - $305.43 $157,586 - $179,287
-587 Reduced 2.31%
24,857 $7.24 Million
Q2 2019

Aug 02, 2019
SELL
$257.51 - $295.55 $128,755 - $147,775
-500 Reduced 1.93%
25,444 $7.47 Million
Q1 2019

Apr 30, 2019
SELL
$212.17 - $273.72 $89,111 - $114,962
-420 Reduced 1.59%
25,944 $7.1 Million
Q4 2018

Jan 29, 2019
SELL
$208.47 - $251.98 $80,469 - $97,264
-386 Reduced 1.44%
26,364 $5.9 Million
Q3 2018

Nov 02, 2018
SELL
$205.57 - $244.32 $59,615 - $70,852
-290 Reduced 1.07%
26,750 $6.53 Million
Q2 2018

Jul 23, 2018
BUY
$203.14 - $219.53 $392,466 - $424,131
1,932 Added 7.69%
27,040 $5.6 Million
Q1 2018

Apr 19, 2018
SELL
$192.98 - $224.11 $30,490 - $35,409
-158 Reduced 0.63%
25,108 $5.18 Million
Q4 2017

Jan 31, 2018
SELL
$182.03 - $200.37 $36,406 - $40,074
-200 Reduced 0.79%
25,266 $4.8 Million
Q3 2017

Nov 03, 2017
BUY
$171.74 - $194.04 $4.37 Million - $4.94 Million
25,466
25,466 $4.82 Million

Others Institutions Holding TMO

# of Institutions
2,778
Shares Held
340M
Call Options Held
1.42M
Put Options Held
2.15M
View Full List

About THERMO FISHER SCIENTIFIC INC.

TMO Quotes by TradingView
  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $241B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track John G Ullman & Associates Inc Portfolio

Follow John G Ullman & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of John G Ullman & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on John G Ullman & Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email